Image2_Effects of Temperature and Additives on NOx Emission From Combustion of Fast-Growing Grass.PNG by Haili Liu (395833)

“…At combustion temperatures of 600, 700, 750, 800, and 850°C, the optimal conditions to limit NO_x emissions were 5% SiO₂, 3% Al₂O₃, 3% Ca(OH)₂, 15% Al₂O₃, and 3% SiO₂ (or 3% Al₂O₃), respectively; the corresponding emission peaks decreased by 43.59, 44.21, 47.99, 24.18, and 30.60% (or 31.51%), with denitration rates of 63.28, 50.34, 57.44, 27.05, and 27.34% (or 27.28%), respectively.…”

Adsorption of free radical TEMPO onto Al₂O₃ nanoparticles and evaluation of radical scavenging activity by Soheyl Alidoust (12105780)

“…It is found that Al₂O₃ nanoparticles have efficient radical scavenging activity (RSA) in the range of 50–72%. Approximately, a linear relationship between dielectric constant of solvent and the absorption percentage of TEMPO over Al₂O₃ nanoparticles is achieved. …”

Image1_Effects of Temperature and Additives on NOx Emission From Combustion of Fast-Growing Grass.PNG by Haili Liu (395833)

“…At combustion temperatures of 600, 700, 750, 800, and 850°C, the optimal conditions to limit NO_x emissions were 5% SiO₂, 3% Al₂O₃, 3% Ca(OH)₂, 15% Al₂O₃, and 3% SiO₂ (or 3% Al₂O₃), respectively; the corresponding emission peaks decreased by 43.59, 44.21, 47.99, 24.18, and 30.60% (or 31.51%), with denitration rates of 63.28, 50.34, 57.44, 27.05, and 27.34% (or 27.28%), respectively.…”

DataSheet1_Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Meta... by Xing Lin (534240)

“…The rats were intragastrically administered with 50% CCl₄ for 9 weeks to induce hepatic fibrosis, followed by various agents for 6 weeks. …”

DataSheet2_Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K/Akt/mTOR and NF-κB Pathways: Based on Transcriptomics and Meta... by Xing Lin (534240)

“…The rats were intragastrically administered with 50% CCl₄ for 9 weeks to induce hepatic fibrosis, followed by various agents for 6 weeks. …”

Data_Sheet_1_Unraveling shared susceptibility loci and Mendelian genetic associations linking educational attainment with multiple neuropsychiatric disorders.docx by Dongze Chen (12283640)

“…MR confirmed higher genetically predicted EA lower the risk of ADHD (OR_IVW: 0.50; 95% CI: 0.39 to 0.63) and genetically predicted ADHD decreased the risk of EA (Causal effect: −2.8 months; 95% CI: −3.9 to −1.8).…”

Table_1_Genetic polymorphisms in CYP4F2 may be associated with lung cancer risk among females and no-smoking Chinese population.docx by Hongyang Shi (836187)

“…</p>Results<p>This study observed that rs12459936 was linked to an increased risk of LC in no-smoking participants (allele: OR = 1.38, p = 0.035; homozygote: OR = 2.00, p = 0.035; additive: OR = 1.40, p = 0.034) and females (allele: OR = 1.64, p = 0.002; homozygote: OR = 2.57, p = 0.006; heterozygous: OR = 2.56, p = 0.001; dominant: OR = 2.56, p < 0.002; additive: OR = 1.67, p = 0.002). Adversely, there was a significantly decreased LC risk for rs3093110 in no-smoking participants (heterozygous: OR = 0.56, p = 0.027; dominant: OR = 0.58, p = 0.035), rs3093193 (allele: OR = 0.66, p = 0.016; homozygote: OR = 0.33, p = 0.011; recessive: OR = 0.38, p = 0.021; additive: OR = 0.64, p = 0.014), rs3093144 (recessive: OR = 0.20, p = 0.045), and rs3093110 (allele: OR = 0.54, p = 0.010; heterozygous: OR = 0.50, p = 0.014; dominant: OR = 0.49, p = 0.010; additive: OR = 0.54, p = 0.011) in females.…”

Image1_Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats.TIF by Derrick Crawford (12414670)

“…Molar but not incisor tooth movement was inhibited over 50% by injection of the NO releasing nanoparticles. …”

Data_Sheet_1_Algal proliferation risk assessment using Vine Copula-based coupling methods in the South-to-North Water Diversion Project of China.PDF by Xizhi Nong (15310423)

“…The results showed that the WT gradually decreased from upstream to downstream, with a narrow range of 16.6–17.4°C, and the annual average concentrations of DO showed a gradual increase from upstream to downstream. …”

<i>vt34</i> exhibits DA-dependent behaviors that parallel <i>dat-1</i> mutants. by Sarah B. Robinson (6693899)

“…<p>(A) <i>vt34</i> Swip is dependent on DOP-3 and CAT-2. …”

Stable RNA levels. by Zhongneng Xu (11177972)

“…The survival rate decreases at older RNA ages, i.e., the type B RNA survival rate is shown in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009188#pcbi.1009188.s003" target="_blank">S2 Table</a>. …”

Image2_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

“…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”

Image_2_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_1_Physical Responses of Pinctada fucata to Salinity Stress.TIF by Jingru Yang (2626306)

“…In this study, the salinity of 35‰ was used as the control, while the salinities of 20 and 50% salinity were used as the low and high salt treatment groups, respectively. …”

Image_3_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Image_4_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.JPEG by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”

Supplementary file 1_Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.doc by Zhenghao Wu (9732511)

“…</p>Methods<p>In vivo experiments, bile duct ligation (BDL) induced PHT models were conducted in rats, followed by a 4-week FN treatment (50 mg/kg/day) administered via gavage. …”

Image1_Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.TIF by Qian Wang (32718)

“…<p>Cholestasis is a clinical syndrome triggered by the accumulation and aggregation of bile acids by subsequent inflammatory responses. …”

Data_Sheet_1_Efficacy and safety of anti-vascular endothelial growth factor agents in the treatment of primary pterygium.PDF by Bowen Zhang (595078)

“…Anti-VEGF agents statistically decreased recurrence rate of pterygium following surgery (RR 0.47, 95% CI 0.31–0.74, P < 0.001). …”